SUWANEE, GA--(Marketwire - November 26, 2007) - Oncologix Tech Inc. (OTCBB: OCLG) announced today that it completed animal studies with rabbits, fulfilling four of the six objectives needed for the FDA IDE submission and will need to test the Oncosphere with another animal model to demonstrate the final two objectives. Additionally, Oncologix Tech announced that it intends to apply for ISO certification and CE Mark to allow for commercialization of the Oncosphere in the European Union in 2008.
